Kaufman Michele B
P T. 2018 Jan;43(1):22-60.
Latanoprostene bunod ophthalmic solution (Vyzulta) for the reduction of intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus infection and disease after stem cell transplant; benralizumab (Fasenra) for the add-on maintenance treatment of severe asthma of an eosinophilic phenotype.
用于降低眼压的拉坦前列素贝诺酯眼用溶液（Vyzulta）；用于预防干细胞移植后巨细胞病毒感染和疾病的来特莫韦（Prevymis）；用于嗜酸性粒细胞表型重度哮喘附加维持治疗的贝那利珠单抗（Fasenra）。
